The global Continuous Glucose Monitoring Devices market size was valued at US$ 4511.7 million in 2023. With growing demand in downstream market, the Continuous Glucose Monitoring Devices is forecast to a readjusted size of US$ 5872.7 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Continuous Glucose Monitoring Devices market. Continuous Glucose Monitoring Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Continuous Glucose Monitoring Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Continuous Glucose Monitoring Devices market.
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
Global Continuous Glucose Monitoring Systems key players include Dexcom, Abbott Laboratories, Medtronic, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 65%, followed by Europe and Asia-Pacific, both have a share about 30 percent.
In terms of product, Wearable is the largest segment, with a share about 99%. And in terms of application, the largest application is Adult, followed by Elderly.
Key Features:
The report on Continuous Glucose Monitoring Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Continuous Glucose Monitoring Devices market. It may include historical data, market segmentation by Type (e.g., Sensors, Transmitters & Receivers), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Continuous Glucose Monitoring Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Continuous Glucose Monitoring Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Continuous Glucose Monitoring Devices industry. This include advancements in Continuous Glucose Monitoring Devices technology, Continuous Glucose Monitoring Devices new entrants, Continuous Glucose Monitoring Devices new investment, and other innovations that are shaping the future of Continuous Glucose Monitoring Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Continuous Glucose Monitoring Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Continuous Glucose Monitoring Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Continuous Glucose Monitoring Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Continuous Glucose Monitoring Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Continuous Glucose Monitoring Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Continuous Glucose Monitoring Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Continuous Glucose Monitoring Devices market.
Market Segmentation:
Continuous Glucose Monitoring Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Sensors
Transmitters & Receivers
Insulin Pumps
Segmentation by application
Diabetic Patients
Healthy Individuals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Echo Therapeutics, Inc.
Dexcom, Inc.
GlySens Incorporated
Medtronic plc
Senseonics Holdings, Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AgaMatrix, Inc.
Glucovation
GlySure
Arkray USA, Inc.
OrSense
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Continuous Glucose Monitoring Devices Market Size 2019-2030
2.1.2 Continuous Glucose Monitoring Devices Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Continuous Glucose Monitoring Devices Segment by Type
2.2.1 Sensors
2.2.2 Transmitters & Receivers
2.2.3 Insulin Pumps
2.3 Continuous Glucose Monitoring Devices Market Size by Type
2.3.1 Continuous Glucose Monitoring Devices Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Continuous Glucose Monitoring Devices Market Size Market Share by Type (2019-2024)
2.4 Continuous Glucose Monitoring Devices Segment by Application
2.4.1 Diabetic Patients
2.4.2 Healthy Individuals
2.5 Continuous Glucose Monitoring Devices Market Size by Application
2.5.1 Continuous Glucose Monitoring Devices Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Continuous Glucose Monitoring Devices Market Size Market Share by Application (2019-2024)
3 Continuous Glucose Monitoring Devices Market Size by Player
3.1 Continuous Glucose Monitoring Devices Market Size Market Share by Players
3.1.1 Global Continuous Glucose Monitoring Devices Revenue by Players (2019-2024)
3.1.2 Global Continuous Glucose Monitoring Devices Revenue Market Share by Players (2019-2024)
3.2 Global Continuous Glucose Monitoring Devices Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Continuous Glucose Monitoring Devices by Regions
4.1 Continuous Glucose Monitoring Devices Market Size by Regions (2019-2024)
4.2 Americas Continuous Glucose Monitoring Devices Market Size Growth (2019-2024)
4.3 APAC Continuous Glucose Monitoring Devices Market Size Growth (2019-2024)
4.4 Europe Continuous Glucose Monitoring Devices Market Size Growth (2019-2024)
4.5 Middle East & Africa Continuous Glucose Monitoring Devices Market Size Growth (2019-2024)
5 Americas
5.1 Americas Continuous Glucose Monitoring Devices Market Size by Country (2019-2024)
5.2 Americas Continuous Glucose Monitoring Devices Market Size by Type (2019-2024)
5.3 Americas Continuous Glucose Monitoring Devices Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuous Glucose Monitoring Devices Market Size by Region (2019-2024)
6.2 APAC Continuous Glucose Monitoring Devices Market Size by Type (2019-2024)
6.3 APAC Continuous Glucose Monitoring Devices Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Continuous Glucose Monitoring Devices by Country (2019-2024)
7.2 Europe Continuous Glucose Monitoring Devices Market Size by Type (2019-2024)
7.3 Europe Continuous Glucose Monitoring Devices Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Continuous Glucose Monitoring Devices by Region (2019-2024)
8.2 Middle East & Africa Continuous Glucose Monitoring Devices Market Size by Type (2019-2024)
8.3 Middle East & Africa Continuous Glucose Monitoring Devices Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Continuous Glucose Monitoring Devices Market Forecast
10.1 Global Continuous Glucose Monitoring Devices Forecast by Regions (2025-2030)
10.1.1 Global Continuous Glucose Monitoring Devices Forecast by Regions (2025-2030)
10.1.2 Americas Continuous Glucose Monitoring Devices Forecast
10.1.3 APAC Continuous Glucose Monitoring Devices Forecast
10.1.4 Europe Continuous Glucose Monitoring Devices Forecast
10.1.5 Middle East & Africa Continuous Glucose Monitoring Devices Forecast
10.2 Americas Continuous Glucose Monitoring Devices Forecast by Country (2025-2030)
10.2.1 United States Continuous Glucose Monitoring Devices Market Forecast
10.2.2 Canada Continuous Glucose Monitoring Devices Market Forecast
10.2.3 Mexico Continuous Glucose Monitoring Devices Market Forecast
10.2.4 Brazil Continuous Glucose Monitoring Devices Market Forecast
10.3 APAC Continuous Glucose Monitoring Devices Forecast by Region (2025-2030)
10.3.1 China Continuous Glucose Monitoring Devices Market Forecast
10.3.2 Japan Continuous Glucose Monitoring Devices Market Forecast
10.3.3 Korea Continuous Glucose Monitoring Devices Market Forecast
10.3.4 Southeast Asia Continuous Glucose Monitoring Devices Market Forecast
10.3.5 India Continuous Glucose Monitoring Devices Market Forecast
10.3.6 Australia Continuous Glucose Monitoring Devices Market Forecast
10.4 Europe Continuous Glucose Monitoring Devices Forecast by Country (2025-2030)
10.4.1 Germany Continuous Glucose Monitoring Devices Market Forecast
10.4.2 France Continuous Glucose Monitoring Devices Market Forecast
10.4.3 UK Continuous Glucose Monitoring Devices Market Forecast
10.4.4 Italy Continuous Glucose Monitoring Devices Market Forecast
10.4.5 Russia Continuous Glucose Monitoring Devices Market Forecast
10.5 Middle East & Africa Continuous Glucose Monitoring Devices Forecast by Region (2025-2030)
10.5.1 Egypt Continuous Glucose Monitoring Devices Market Forecast
10.5.2 South Africa Continuous Glucose Monitoring Devices Market Forecast
10.5.3 Israel Continuous Glucose Monitoring Devices Market Forecast
10.5.4 Turkey Continuous Glucose Monitoring Devices Market Forecast
10.5.5 GCC Countries Continuous Glucose Monitoring Devices Market Forecast
10.6 Global Continuous Glucose Monitoring Devices Forecast by Type (2025-2030)
10.7 Global Continuous Glucose Monitoring Devices Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Continuous Glucose Monitoring Devices Product Offered
11.1.3 Abbott Laboratories Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Echo Therapeutics, Inc.
11.2.1 Echo Therapeutics, Inc. Company Information
11.2.2 Echo Therapeutics, Inc. Continuous Glucose Monitoring Devices Product Offered
11.2.3 Echo Therapeutics, Inc. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Echo Therapeutics, Inc. Main Business Overview
11.2.5 Echo Therapeutics, Inc. Latest Developments
11.3 Dexcom, Inc.
11.3.1 Dexcom, Inc. Company Information
11.3.2 Dexcom, Inc. Continuous Glucose Monitoring Devices Product Offered
11.3.3 Dexcom, Inc. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Dexcom, Inc. Main Business Overview
11.3.5 Dexcom, Inc. Latest Developments
11.4 GlySens Incorporated
11.4.1 GlySens Incorporated Company Information
11.4.2 GlySens Incorporated Continuous Glucose Monitoring Devices Product Offered
11.4.3 GlySens Incorporated Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GlySens Incorporated Main Business Overview
11.4.5 GlySens Incorporated Latest Developments
11.5 Medtronic plc
11.5.1 Medtronic plc Company Information
11.5.2 Medtronic plc Continuous Glucose Monitoring Devices Product Offered
11.5.3 Medtronic plc Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Medtronic plc Main Business Overview
11.5.5 Medtronic plc Latest Developments
11.6 Senseonics Holdings, Inc.
11.6.1 Senseonics Holdings, Inc. Company Information
11.6.2 Senseonics Holdings, Inc. Continuous Glucose Monitoring Devices Product Offered
11.6.3 Senseonics Holdings, Inc. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Senseonics Holdings, Inc. Main Business Overview
11.6.5 Senseonics Holdings, Inc. Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Continuous Glucose Monitoring Devices Product Offered
11.7.3 Johnson & Johnson Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Information
11.8.2 F. Hoffmann-La Roche Ltd. Continuous Glucose Monitoring Devices Product Offered
11.8.3 F. Hoffmann-La Roche Ltd. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.8.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.9 AgaMatrix, Inc.
11.9.1 AgaMatrix, Inc. Company Information
11.9.2 AgaMatrix, Inc. Continuous Glucose Monitoring Devices Product Offered
11.9.3 AgaMatrix, Inc. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 AgaMatrix, Inc. Main Business Overview
11.9.5 AgaMatrix, Inc. Latest Developments
11.10 Glucovation
11.10.1 Glucovation Company Information
11.10.2 Glucovation Continuous Glucose Monitoring Devices Product Offered
11.10.3 Glucovation Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Glucovation Main Business Overview
11.10.5 Glucovation Latest Developments
11.11 GlySure
11.11.1 GlySure Company Information
11.11.2 GlySure Continuous Glucose Monitoring Devices Product Offered
11.11.3 GlySure Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 GlySure Main Business Overview
11.11.5 GlySure Latest Developments
11.12 Arkray USA, Inc.
11.12.1 Arkray USA, Inc. Company Information
11.12.2 Arkray USA, Inc. Continuous Glucose Monitoring Devices Product Offered
11.12.3 Arkray USA, Inc. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Arkray USA, Inc. Main Business Overview
11.12.5 Arkray USA, Inc. Latest Developments
11.13 OrSense
11.13.1 OrSense Company Information
11.13.2 OrSense Continuous Glucose Monitoring Devices Product Offered
11.13.3 OrSense Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 OrSense Main Business Overview
11.13.5 OrSense Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
